This inventor holds 2 USPTO granted patents. Top assignees: Eli Lilly and Company, Syngenta Crop Protection Ag. Active years: 1996-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-2026
Title: The Innovative Work of Roger W Tharp-Taylor
Introduction
Roger W Tharp-Taylor is a notable inventor based in Noblesville, Indiana, recognized for his contributions to the field of neurokinin receptor antagonists. His innovative work focuses on creating novel compounds that offer significant advancements in medical research.
Latest Patents
Tharp-Taylor holds a patent for "Bis-piperidinyl non-peptidyl neurokinin receptor antagonists." This invention introduces a new class of compounds that functions as neurokinin receptor antagonists, showcasing his commitment to exploring and developing therapeutic solutions for complex health challenges.
Career Highlights
Roger W Tharp-Taylor is associated with Eli Lilly and Company, a leading pharmaceutical firm. His role there has allowed him to work on impactful projects, contributing to medical advancements through innovative drug development.
Collaborations
Throughout his career, Tharp-Taylor has collaborated with esteemed colleagues such as Sung Y Cho and James Denmore Copp. These partnerships have enhanced the creative process, leading to significant breakthroughs within the realm of pharmacology.
Conclusion
Roger W Tharp-Taylor exemplifies the spirit of innovation within the pharmaceutical industry. His work not only reflects his expertise but also emphasizes the importance of collaboration in achieving groundbreaking inventions that can potentially improve patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile